Esophageal Reflux
6
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Histology Post-Endoscopic Eradication Therapy (EET)
The Effect of Chlorpromazine on Esophageal Sensitivity in Healthy Volunteers.
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)